Avalyn Pharma Inc. Insider Trading
AVLN
Insiders bought $5M and sold $2.62M on the open market.
All of the selling was scheduled in advance under 10b5-1 plans.
Get an email when AVLN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17 – 18 | Lyn Baranowski Chief Executive Officer | Sold10b5-1 plan 5 parts | 52,500 | $27.84 average | $1.46M | 100% | Form 4 |
| Nov 17 | Howard Lazarus Chief Medical Officer | Sold10b5-1 plan 3 parts | 13,300 | $27.90 average | 371K | 100% | Form 4 |
| Nov 17 | Melissa Rhodes Chief Operating Officer | Sold10b5-1 plan 3 parts | 13,300 | $27.90 average | 371K | 100% | Form 4 |
| Nov 17 | Douglas R Carlson See Remarks | Sold10b5-1 plan 3 parts | 14,875 | $27.90 average | 415K | 100% | Form 4 |
| Nov 9 – 10 | FMR LLC Large holder | SoldNo plan 4 parts | 228,454 | $29.33 average | $6.7M | 10% | Form 4 |
| May 1 | Novo Holdings A/S Large holder | Bought | 555,555 | $18.00 | $10M | 17% | Form 4 |
| May 1 | Jill Carroll Director | Bought | 277,778 | $18.00 | $5M | 15% | Form 4 |
| May 1 | Simeon George Large holder | Bought 2 parts | 555,555 | $18.00 average | $10M | 20% | Form 4 |
- Nov 17 – 1810b5-1 planLyn BaranowskiChief Executive Officer · sold 52,500 at avg $27.84$1.46M100% of stake
- Nov 1710b5-1 planHoward LazarusChief Medical Officer · sold 13,300 at avg $27.90371K100% of stake
- Nov 1710b5-1 planMelissa RhodesChief Operating Officer · sold 13,300 at avg $27.90371K100% of stake
- Nov 1710b5-1 planDouglas R CarlsonSee Remarks · sold 14,875 at avg $27.90415K100% of stake
- Nov 9 – 10No planFMR LLCLarge holder · sold 228,454 at avg $29.33$6.7M10% of stake
- May 1Novo Holdings A/SLarge holder · bought 555,555 at $18.00$10M17% of stake
- May 1Jill CarrollDirector · bought 277,778 at $18.00$5M15% of stake
- May 1Simeon GeorgeLarge holder · bought 555,555 at avg $18.00$10M20% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with AVLN
Held by ETFs
AVLN is in 8 US ETFs. The largest of them, with AVLN's weight in each:
iShares Russell 2000 Growth ETFIWO0.02%of the fund
T. Rowe Price Small-Mid Cap ETFTMSL0.07%of the fund
Vanguard Russell 2000 Growth ETFVTWG0.02%of the fund
iShares U.S. Pharmaceuticals ETFIHE0.10%of the fund
State Street SPDR S&P Pharmaceuticals ETFXPH0.78%of the fund
T. Rowe Price Health Care ETFTMED0.18%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AVLN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.